Catalyst Wire Dossier Catalyst Wire Dossier

Vedroprevir

vedroprevir · not specified
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vedroprevir, covering 2016-03-04 to 2016-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis [Phase 2]

See pricing